Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now

"The greatest wealth is health."         - Virgil


      Advertisement

DACRYOSTENOSIS ACQUIRED side effect

What is DACRYOSTENOSIS ACQUIRED ?
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with DACRYOSTENOSIS ACQUIRED

BEXTRA  COSOPT  FORTEO  HUMIRA  NATALIZUMAB  PACLITAXEL  REBIF  RESTASIS  TOBRAMYCIN  VERAMYST  


DACRYOSTENOSIS ACQUIRED : Paclitaxel Side Effects Report #5678832-1
Consumer or non-health professional from UNITED STATES reported PACLITAXEL problem on Mar 13, 2008. Male patient, 66 years of age, was diagnosed with angiosarcoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: dacryostenosis acquired, impaired healing, intraocular pressure increased, punctate keratitis, scar, . PACLITAXEL dosage: 175 MG/M2. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Restasis Side Effects Report #5624835-2
RESTASIS problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 07, 2008. Female patient, 57 years of age, was diagnosed with dry eye and was treated with RESTASIS. After drug was administered, patient experienced the following problems/side effects: dacryostenosis acquired, lacrimation increased, . RESTASIS dosage: unknown. During the same period patient was treated with VITAMIN CAP, SYNTHROID. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Forteo Side Effects Report #5557898-3
Physician from FRANCE reported FORTEO problem on Dec 05, 2007. Female patient, weighting 123.5 lb, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: dacryostenosis acquired, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Veramyst Side Effects Report #5512324-5
VERAMYST problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 24, 2007. Female patient was treated with VERAMYST. After drug was administered, patient experienced the following problems/side effects: dacryostenosis acquired, dry eye, dry mouth, . VERAMYST dosage: unknown. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Forteo Side Effects Report #5528926-6
Consumer or non-health professional from FRANCE reported FORTEO problem on Nov 15, 2007. Female patient, 77 years of age, was diagnosed with osteoporosis and was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: dacryostenosis acquired, . FORTEO dosage: unknown. Patient was hospitalized. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Tobramycin Side Effects Report #5465195-X
TOBRAMYCIN SULPHATE problem was reported by a Consumer or non-health professional from UNITED STATES on July 09, 2007. Male patient was diagnosed with conjunctivitis and was treated with TOBRAMYCIN SULPHATE. After drug was administered, patient experienced the following problems/side effects: dacryostenosis acquired, . TOBRAMYCIN SULPHATE dosage: unknown. Patient was hospitalized. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Rebif Side Effects Report #5593266-6
Health Professional from UNITED STATES reported REBIF problem on Jan 04, 2008. Female patient, 42 years of age, weighting 210.0 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: cataract, dacryostenosis acquired, iritis, rash maculo-papular, vitreous floaters, . REBIF dosage: unknown. During the same period patient was treated with PREDNISONE, WELLBUTRIN. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Humira Side Effects Report #5560236-3
HUMIRA problem was reported by a Physician from UNITED STATES on Nov 01, 2007. Female patient, weighting 152.1 lb, was diagnosed with crohn's disease and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: crohn's disease, dacryostenosis acquired, eye disorder, eye infection bacterial, . HUMIRA dosage: unknown. During the same period patient was treated with WARFARIN, LANSOPRAZOLE. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Natalizumab Side Effects Report #5414679-9
Health Professional from UNITED STATES reported NATALIZUMAB problem on July 28, 2007. Female patient, 56 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: corneal disorder, dacryostenosis acquired, dehydration, eye pain, headache, influenza, mouth breathing, multiple sclerosis relapse, nausea, . NATALIZUMAB dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Paclitaxel Side Effects Report #5402059-1
PACLITAXEL problem was reported by a Health Professional from UNITED STATES on July 17, 2007. Male patient, 66 years of age, was diagnosed with angiosarcoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: cutis laxa, dacryostenosis acquired, ectropion, intraocular pressure increased, mucous membrane disorder, punctate keratitis, scar, . PACLITAXEL dosage: 175 MG/M2. Patient was hospitalized. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Paclitaxel Side Effects Report #5402059-1
Health Professional from UNITED STATES reported PACLITAXEL problem on July 17, 2007. Male patient, 66 years of age, was diagnosed with angiosarcoma and was treated with PACLITAXEL. After drug was administered, patient experienced the following problems/side effects: cutis laxa, dacryostenosis acquired, ectropion, intraocular pressure increased, mucous membrane disorder, punctate keratitis, scar, . PACLITAXEL dosage: 175 MG/M2. Patient was hospitalized. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Cosopt Side Effects Report #5507806-6
COSOPT problem was reported by a Physician from UNITED STATES on Oct 26, 2007. Female patient, 81 years of age, was diagnosed with glaucoma and was treated with COSOPT. After drug was administered, patient experienced the following problems/side effects: arthritis, back pain, dacryostenosis acquired, eye discharge, eyelid margin crusting, glaucoma, musculoskeletal stiffness, rectal haemorrhage, thrombosis, . COSOPT dosage: unknown. During the same period patient was treated with XALATAN, ALPHAGAN, ASPIRIN, OMEGA. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Bextra Side Effects Report #5499935-0
Consumer or non-health professional from UNITED STATES reported BEXTRA problem on Oct 15, 2007. Female patient was diagnosed with arthralgia and was treated with BEXTRA. After drug was administered, patient experienced the following problems/side effects: arthropathy, candidiasis, dacryostenosis acquired, depression, dyspnoea exertional, oesophagitis, pulmonary embolism, pulmonary infarction, rash, . BEXTRA dosage: unknown. Patient was hospitalized. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Natalizumab Side Effects Report #5394836-0
NATALIZUMAB problem was reported by a Health Professional from UNITED STATES on July 10, 2007. Female patient, 56 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: bacterial infection, corneal disorder, dacryostenosis acquired, dehydration, eye burns, influenza, parotitis, sinusitis, . NATALIZUMAB dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.

DACRYOSTENOSIS ACQUIRED : Natalizumab Side Effects Report #5394836-0
Health Professional from UNITED STATES reported NATALIZUMAB problem on July 10, 2007. Female patient, 56 years of age, was diagnosed with multiple sclerosis and was treated with NATALIZUMAB. After drug was administered, patient experienced the following problems/side effects: bacterial infection, corneal disorder, dacryostenosis acquired, dehydration, eye burns, influenza, parotitis, sinusitis, . NATALIZUMAB dosage: 300 MG;QM;IV. Patient was hospitalized. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about DACRYOSTENOSIS ACQUIRED side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about DACRYOSTENOSIS ACQUIRED